Treatment of metastatic colorectal Cancer Aflibercept/FOLFIRI can be widely used in the second Therapy Line

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷 / 06期
关键词：
FLUOROURACIL; LEUCOVORIN; IRINOTECAN; PLACEBO;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Radiofrequency Ablation with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer
    Agarwal, Archana
    Daly, Kevin Pelham
    Butler-Bowen, Harriet
    Saif, Muhammad Wasif
    ANTICANCER RESEARCH, 2014, 34 (11) : 6775 - 6778
  • [32] FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer
    Carola, Candice
    Ghiringhelli, Francois
    Kim, Stefano
    Andre, Thierry
    Barlet, Juliette
    Bengrine-Lefevre, Leila
    Marijon, Helene
    Garcia-Larnicol, Marie-Line
    Borg, Christophe
    Dainese, Linda
    Steuer, Nils
    Richa, Hubert
    Benetkiewicz, Magdalena
    Larsen, Annette K.
    de Gramont, Aimery
    Chibaudel, Benoist
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2018, 9 (05): : 110 - 118
  • [33] Bevacizumab and aflibercept in second-line metastatic colorectal cancer: 12 years of experience
    Raquel Claramunt García
    Carmen Lucía Muñoz Cid
    Andrés Sánchez Ruiz
    Juan Francisco Marín Pozo
    European Journal of Clinical Pharmacology, 2022, 78 : 287 - 291
  • [34] A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
    Toledano-Fonseca, M.
    Gomez-Espana, M. A.
    Elez, E.
    Gravalos, C.
    Garcia-Alfonso, P.
    Rodriguez, R.
    Losa, F.
    Diaz, I. Ales
    Grana, B.
    Valladares-Ayerbes, M.
    Garcia-Ortiz, M. V.
    Polo, E.
    Salgado, M.
    Rivera, F.
    Safont, M. J.
    Salud, A.
    Ruiz-Casado, A.
    Tabernero, J. M.
    Riesco, M. C.
    Rodriguez-Ariza, A.
    Aranda, E.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 159
  • [35] A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
    Rodriguez-Ariza, A.
    Espana, M. A. Gomez
    Fernandez, M. E. Elez
    Castro, M. C. Gravalos
    Alfonso, P. Garcia
    Losa, F.
    Diaz, I. C. Ales
    Suarez, B. Grana
    Gallego, I.
    Garcia-Ortiz, M. V.
    Marques, E. Polo
    Fernandez, M. Salgado
    Herrero, F. Rivera
    Aguileria, M. J. Safont
    Salvia, M. A. Salud
    Ruiz-Casado, A.
    Tabernero, J.
    Martinez, M. C. Riesco
    Toledano-Fonseca, M.
    Aguilar, E. Ara
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S693 - S693
  • [36] Bevacizumab and aflibercept in second-line metastatic colorectal cancer: 12 years of experience
    Claramunt Garcia, Raquel
    Munoz Cid, Carmen Lucia
    Sanchez Ruiz, Andres
    Marin Pozo, Juan Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (02) : 287 - 291
  • [37] Aflibercept in combination with FOLFIRI for the second-line treatment of patients with metastatic colorectal cancer: Interim safety data from the global Aflibercept Safety and Quality-of-Life Program (ASQoP and AFEQT studies)
    Sobrero, A.
    Bordonaro, R.
    Frassineti, L.
    Di Bartolomeo, M.
    Thomas, A. L.
    Taieb, J.
    Lledo, G.
    Moore, Y.
    Zilocchi, C.
    Ferry, D. R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S521 - S521
  • [38] PANITUMUMAB WITH FOLFIRI VS FOLFIRI ALONE: A RANDOMISED PHASE 3 STUDY FOR THE SECOND LINE TREATMENT OF PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (mCRC)
    Andre, T.
    Peeters, M.
    Price, T.
    Hotko, Y.
    Cervantes, A.
    Ducreux, M.
    Chan, E.
    Lordick, F.
    Rong, A.
    Gansert, J.
    ANNALS OF ONCOLOGY, 2010, 21 : I13 - I13
  • [39] FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials
    Giordano Domenico Beretta
    Fausto Petrelli
    Sergio Stinco
    Mary Cabiddu
    Mara Ghilardi
    Michela Squadroni
    Karen Borgonovo
    Sandro Barni
    Medical Oncology, 2013, 30
  • [40] Evaluation of aflibercept in the treatment of metastatic colorectal cancer
    Macarulla, Teresa
    Sauri, Tamara
    Tabernero, Josep
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (10) : 1493 - 1505
12345